Lobeglitazone has long-term safety profile, good glycemic-lowering effect and long-term durability of glycemic control in real-world clinical settings.
María Nieves García SantosSebastián Ubiría Zubizarreta
José L. RaymondJosé L. Raymond
María Jesús Aguado SánchezJavier Sansa TorresMaría Dolores Martínez Mazo